From its new premises in Medicon Village in Lund, BrainLit is stepping up the pace of adoption of its patented biocentric light, giving people the energy of daylight indoors. Reference installations for large global customers and an oversubscribed new share issue are the basis for an international expansion that is gaining momentum.
The 2017 Nobel Prize in Physiology or Medicine was awarded for research on our circadian rhythms and explains how plants, animals, and people optimize their physiology to prepare for the various phases of the day. These phases are affected primarily by daylight. Our exposure to daylight affects how we sleep and thus our wellbeing. We now spend much less time in daylight than did the ten thousand generations of humankind that came before us. BrainLit has a solution to this, consisting of sensors and algorithms that control lighting based on the daylight needs of individuals or groups. In practice, BrainLit’s system mimics daylight indoors based on individual needs.
Every day, more than 5,000 people now spend time in reference installation environments where BrainLit’s system controls the lighting. There is huge interest in the system, which has been bought by several prestigious customers. A recent new share issue in BrainLit, with Carnegie Investment Bank as the financial advisor and an expected range of SEK 80 to 100 million, was oversubscribed in a matter of days. This is testament to the faith that many people have in the company.
– Our idea is simple and based on using advanced technology that allows lighting to mimic daylight in order to make us feel good. Strong patent families and the keen involvement of existing and new owners with extensive experience of global entrepreneurship are invaluable as we break new ground within an exciting new area of technology, says BrainLit CEO Niclas Möttus Olsson.
BrainLit believes that the number of reference installations has now reached critical mass. Consequently, the company is now preparing to expand internationally by way of partners and the establishment of its own sales channels. One step in this development was the recent move to Medicon Village’s newest building, “The Spark”, in Lund, where the company has rented the entire top floor in order to have room to expand its workforce.
BioCentric Lighting, BrainLit’s BCL™ system, and the understanding of the impact light has on our biology are all evolving thanks to collaboration with the company’s scientific council, consisting of associate Professor Klas Sjöberg of Gastro Centre Skåne at Skåne University Hospital in Lund, Professor Thorbjörn Laike of the Department of Architecture and Built Environment at the Faculty of Engineering (LTH) at Lund University, Professor Lennart Minthon of the Department of Clinical Sciences at Skåne University Hospital in Lund, Professor Lars Samuelson of the Department of Physics at the Faculty of Engineering (LTH) at Lund University, and Dr. Madeleine Selvander, ophthalmologist at Sundets Ögonläkare.
For more information:
Niclas Möttus Olsson, CEO at BrainLit AB, +46 (0)720-25 55 63
BrainLit was founded in 2012 by, among others, Tord Wingren, a telecoms aficionado and one of the creators of Bluetooth. Fast forward to the present day and the company is run from its head office in Medicon Village in Lund by CEO Niclas Olsson and chair of the board Mats Leifland with the support of a dedicated team, a board made up of well-known experts in the field, and commercial and scientific councils based on a number of patent families. The objective is to spread biocentric light around the world to increase the wellbeing of mankind under the slogan “Energizing People™”.
